Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion description "[We retrospectively evaluated the efficacy and safety of high-dose erlotinib in EGFR-mutant non-small cell lung cancer (NSCLC) patients with refractory LM after failure of standard-dose EGFR-TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion evidence source_evidence_literature NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion SIO_000772 25921002 NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion wasDerivedFrom befree-2016 NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion wasGeneratedBy ECO_0000203 NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.